Shanthi Narla is a Dermatology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 64 publications with 1,627 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Avenue
Dermatology
Milwaukee, WI 532263522
Telephone
414-805-5320Provider last certified this registry record 6 Nov 2023.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20252 payments
- Galderma Laboratories, L.P.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
37.4%Azole Antifungal28%Ketoconazole100%Part D≥99 patientsLincosamide Antibacterial5.9%Clindamycin Phosphate73%Clindamycin Phos-Benzoyl Perox27%Part D<11 patients+ 1 more class in this area
Dermatology
19.3%Corticosteroid11.8%Triamcinolone Acetonide100%Part D≥64 patientsInterleukin-4 Receptor alpha Antagonist4%Dupixent Pen100%Part D<11 patients+ 2 more classes in this area
Sensory organs
17.7%Corticosteroid15.6%Clobetasol Propionate82%Hydrocortisone19%Part D≥45 patientsAminoglycoside Antibacterial2.2%Gentamicin Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- JAAD CME Part 2: Clinical Evidence and Safety Considerations for GLP-1 Receptor Agonists in Dermatology
Journal of the American Academy of Dermatology
2026 - JAAD CME Part 1: Mechanism of Action of GLP-1 Receptor Agonists and Potential Pathways in Skin Health
Journal of the American Academy of Dermatology
2026 - Current updates in the epidemiology and comorbidities of atopic dermatitis
Annals of Allergy Asthma & Immunology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”